Mirabella Financial Services LLP Grows Position in HCA Healthcare, Inc. $HCA

Mirabella Financial Services LLP grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 112.2% in the third quarter, HoldingsChannel reports. The institutional investor owned 12,715 shares of the company’s stock after buying an additional 6,724 shares during the period. Mirabella Financial Services LLP’s holdings in HCA Healthcare were worth $5,408,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at about $1,021,000. NewEdge Advisors LLC boosted its position in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the last quarter. Cetera Investment Advisers increased its stake in shares of HCA Healthcare by 0.7% in the second quarter. Cetera Investment Advisers now owns 32,379 shares of the company’s stock worth $12,405,000 after acquiring an additional 211 shares during the period. Finally, Kingsview Wealth Management LLC lifted its position in HCA Healthcare by 16.3% during the second quarter. Kingsview Wealth Management LLC now owns 1,852 shares of the company’s stock valued at $710,000 after purchasing an additional 259 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of a number of recent research reports. KeyCorp set a $503.00 price objective on HCA Healthcare in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lifted their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Jefferies Financial Group upped their price objective on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Finally, JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research report on Friday, February 20th. Sixteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 15,214 shares of company stock worth $7,797,595 over the last three months. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $502.08 on Thursday. The stock has a 50 day simple moving average of $509.18 and a 200-day simple moving average of $472.27. HCA Healthcare, Inc. has a 1-year low of $314.43 and a 1-year high of $556.52. The company has a market cap of $112.25 billion, a price-to-earnings ratio of 17.69, a PEG ratio of 1.56 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is presently 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.